Cargando…
Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential
BACKGROUND: Cone degeneration is the hallmark of the inherited retinal disease retinitis pigmentosa. We have previously identified a trophic factor "Rod-derived Cone Viability Factor (RdCVF) that is secreted by rods and promote cone viability in a mouse model of the disease. RESULTS: Here we re...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central|1
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2064930/ https://www.ncbi.nlm.nih.gov/pubmed/17764561 http://dx.doi.org/10.1186/1471-2199-8-74 |
_version_ | 1782137641139961856 |
---|---|
author | Chalmel, Frédéric Léveillard, Thierry Jaillard, Céline Lardenois, Aurélie Berdugo, Naomi Morel, Emmanuelle Koehl, Patrice Lambrou, George Holmgren, Arne Sahel, José A Poch, Olivier |
author_facet | Chalmel, Frédéric Léveillard, Thierry Jaillard, Céline Lardenois, Aurélie Berdugo, Naomi Morel, Emmanuelle Koehl, Patrice Lambrou, George Holmgren, Arne Sahel, José A Poch, Olivier |
author_sort | Chalmel, Frédéric |
collection | PubMed |
description | BACKGROUND: Cone degeneration is the hallmark of the inherited retinal disease retinitis pigmentosa. We have previously identified a trophic factor "Rod-derived Cone Viability Factor (RdCVF) that is secreted by rods and promote cone viability in a mouse model of the disease. RESULTS: Here we report the bioinformatic identification and the experimental analysis of RdCVF2, a second trophic factor belonging to the Rod-derived Cone Viability Factor family. The mouse RdCVF gene is known to be bifunctional, encoding both a long thioredoxin-like isoform (RdCVF-L) and a short isoform with trophic cone photoreceptor viability activity (RdCVF-S). RdCVF2 shares many similarities with RdCVF in terms of gene structure, expression in a rod-dependent manner and protein 3D structure. Furthermore, like RdCVF, the RdCVF2 short isoform exhibits cone rescue activity that is independent of its putative thiol-oxydoreductase activity. CONCLUSION: Taken together, these findings define a new family of bifunctional genes which are: expressed in vertebrate retina, encode trophic cone viability factors, and have major therapeutic potential for human retinal neurodegenerative diseases such as retinitis pigmentosa. |
format | Text |
id | pubmed-2064930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central|1 |
record_format | MEDLINE/PubMed |
spelling | pubmed-20649302007-11-07 Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential Chalmel, Frédéric Léveillard, Thierry Jaillard, Céline Lardenois, Aurélie Berdugo, Naomi Morel, Emmanuelle Koehl, Patrice Lambrou, George Holmgren, Arne Sahel, José A Poch, Olivier BMC Mol Biol Research Article BACKGROUND: Cone degeneration is the hallmark of the inherited retinal disease retinitis pigmentosa. We have previously identified a trophic factor "Rod-derived Cone Viability Factor (RdCVF) that is secreted by rods and promote cone viability in a mouse model of the disease. RESULTS: Here we report the bioinformatic identification and the experimental analysis of RdCVF2, a second trophic factor belonging to the Rod-derived Cone Viability Factor family. The mouse RdCVF gene is known to be bifunctional, encoding both a long thioredoxin-like isoform (RdCVF-L) and a short isoform with trophic cone photoreceptor viability activity (RdCVF-S). RdCVF2 shares many similarities with RdCVF in terms of gene structure, expression in a rod-dependent manner and protein 3D structure. Furthermore, like RdCVF, the RdCVF2 short isoform exhibits cone rescue activity that is independent of its putative thiol-oxydoreductase activity. CONCLUSION: Taken together, these findings define a new family of bifunctional genes which are: expressed in vertebrate retina, encode trophic cone viability factors, and have major therapeutic potential for human retinal neurodegenerative diseases such as retinitis pigmentosa. BioMed Central|1 2007-08-31 /pmc/articles/PMC2064930/ /pubmed/17764561 http://dx.doi.org/10.1186/1471-2199-8-74 Text en Copyright © 2007 Chalmel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Chalmel, Frédéric Léveillard, Thierry Jaillard, Céline Lardenois, Aurélie Berdugo, Naomi Morel, Emmanuelle Koehl, Patrice Lambrou, George Holmgren, Arne Sahel, José A Poch, Olivier Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential |
title | Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential |
title_full | Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential |
title_fullStr | Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential |
title_full_unstemmed | Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential |
title_short | Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential |
title_sort | rod-derived cone viability factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2064930/ https://www.ncbi.nlm.nih.gov/pubmed/17764561 http://dx.doi.org/10.1186/1471-2199-8-74 |
work_keys_str_mv | AT chalmelfrederic rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential AT leveillardthierry rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential AT jaillardceline rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential AT lardenoisaurelie rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential AT berdugonaomi rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential AT morelemmanuelle rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential AT koehlpatrice rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential AT lambrougeorge rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential AT holmgrenarne rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential AT saheljosea rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential AT pocholivier rodderivedconeviabilityfactor2isanovelbifunctionalthioredoxinlikeproteinwiththerapeuticpotential |